• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Health News > June 16, 2010

      Green Tea Helps Chronic Leukemia Treatment

      Posted AtTimesofindia.Indiatimes.com

      Researchers at Mayo Clinic say that use of the chemical epigallocatechin gallate (EGCG) – the major component of green tea, may reduce the number of leukemia cells in patients with CLL. This laboratory finding was followed by a successful phase I clinical trial -- the first time green tea extract had been studied in CLL patients.

      “Although only a comparative phase III trial can determine whether EGCG can delay progression of CLL, the benefits we have seen in most CLL patients who use the chemical suggest that it has modest clinical activity and may be useful for stabilizing this form of leukemia, potentially slowing it down,” says Tait Shanafelt, M.D., a Mayo Clinic hematologist and lead author of the study.

      “These studies advance the notion that a nutraceutical like EGCG can and should be studied as cancer preventives,” says Neil Kay, M.D., a hematology researcher whose laboratory first tested the green tea extract in leukemic blood cells from CLL patients. “Using nontoxic chemicals to push back cancer growth to delay the need for toxic therapies is a worthy goal in oncology research -- particularly for forms of cancer initially managed by observation such as CLL.”

      Scientists caution though, that EGCG is not a substitute for chemotherapy. CLL is a blood cancer that is a hybrid between leukemia and lymphoma. Progression of the disease is measured by the quantity of leukemia cells in the blood and bone marrow as well as enlargement of lymph nodes due to infiltration by the leukemia cells.

      After the phase I study, where scientists found a reduced cell count in 60 per cent patients, they launched their phase II clinical trial in an additional 36 patients. Results from 41 patients who have completed the study show that 31 percent of patients had a 20 percent or greater sustained reduction in blood leukemia count, and 69 percent of patients with enlarged lymph nodes saw a reduction of node size of 50 percent or greater.

      The researchers also studied the side effects, since EGCG was being studied in patients who did not otherwise need treatment. “All in all, the treatment was well tolerated with very mild side effects in most patients,” Shanafelt says.

      Kay however warns that not all CLL patients can use the treatment without consulting their oncologists and proper lab tests. The findings are to be presented Monday, June 7, during the annual meeting of the American Society of Clinical Oncology (ASCO).

      June 16, 2010


      Share this Article!

    Back to top^